Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Experimental Hematology & Oncology
|
November 20, 2021
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Jun Zhang, Xilin He, Yajie Wan, et al.
Molecular Genetics and Genomics : MGG
|
February 22, 2023
A comprehensive pan-cancer analysis reveals cancer-associated robust isomiR expression landscapes in miRNA arm switching
Li Guo, Dekang Ren, Yuting Zhang, et al.
Journal of Cellular and Molecular Medicine
|
January 17, 2020
Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer
Yan Liu, Hang Song, Shiyi Yu, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 9, 2019
Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage
Shiyi Yu, Xue Gong, Zhifang Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 8, 2023
An Immunomodulatory Zinc-Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte-Assisted Cascade Immune Activation
Jing Zhao, Lingxiao Zhang, Pin Li, et al.
Journal of Cancer Research and Clinical Oncology
|
May 15, 2024
Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors
Zhehao Fan, Xiaofeng Liu, Ning Wang, et al.
Advanced Healthcare Materials
|
September 12, 2023
Leveraging Coupling Effect-Enhanced Surface Plasmon Resonance of Ruthenium Nanocrystal-Decorated Mesoporous Silica Nanoparticles for Boosted Photothermal Immunotherapy
Pin Li, Zheng Chen, Fan Xia, et al.
Journal of Gastroenterology and Hepatology
|
May 8, 2026
Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Mina Ehab Ayad, Shiyi Yu, Safia El Shennawy, et al.
Aging
|
December 19, 2019
ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling
Shiyi Yu, Meng Zhang, Ling Huang, et al.
Oncotarget
|
January 22, 2015
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
Shiyi Yu, Xiuxiu Cai, Chenxi Wu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Experimental Hematology & Oncology
|
November 20, 2021
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Jun Zhang, Xilin He, Yajie Wan, et al.
Molecular Genetics and Genomics : MGG
|
February 22, 2023
A comprehensive pan-cancer analysis reveals cancer-associated robust isomiR expression landscapes in miRNA arm switching
Li Guo, Dekang Ren, Yuting Zhang, et al.
Journal of Cellular and Molecular Medicine
|
January 17, 2020
Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer
Yan Liu, Hang Song, Shiyi Yu, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 9, 2019
Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage
Shiyi Yu, Xue Gong, Zhifang Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 8, 2023
An Immunomodulatory Zinc-Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte-Assisted Cascade Immune Activation
Jing Zhao, Lingxiao Zhang, Pin Li, et al.
Journal of Cancer Research and Clinical Oncology
|
May 15, 2024
Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors
Zhehao Fan, Xiaofeng Liu, Ning Wang, et al.
Advanced Healthcare Materials
|
September 12, 2023
Leveraging Coupling Effect-Enhanced Surface Plasmon Resonance of Ruthenium Nanocrystal-Decorated Mesoporous Silica Nanoparticles for Boosted Photothermal Immunotherapy
Pin Li, Zheng Chen, Fan Xia, et al.
Journal of Gastroenterology and Hepatology
|
May 8, 2026
Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Mina Ehab Ayad, Shiyi Yu, Safia El Shennawy, et al.
Aging
|
December 19, 2019
ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling
Shiyi Yu, Meng Zhang, Ling Huang, et al.
Oncotarget
|
January 22, 2015
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
Shiyi Yu, Xiuxiu Cai, Chenxi Wu, et al.
Page
of 4